Certis Biologicals
Ryutaro Matsuhashi's work experience includes holding the position of Vice President - Latin America at Certis Biologicals since July 2021. Prior to this, they served as the Vice President International at Certis Biologicals from February 2016 to June 2021. Before joining Certis Biologicals, they worked at Mitsui & Co., Ltd. as a Manager from April 2010 to February 2016.
Ryutaro Matsuhashi obtained their Bachelor's Degree in Pharmacy from Kanazawa University, where they attended from 2004 to 2008. Following this, they pursued a Master's Degree in Bioengineering and Biomedical Engineering at The University of Tokyo, completing their studies from 2008 to 2010.
Certis Biologicals
Certis Biologicals is a pioneer in the development of biological pesticides and has become one of the world’s leading manufacturers and distributors of biopesticides. We specialize in: Biological product development, from screening to formulation to field development Manufacturing: fermentation and formulation Global registrations for biological products Global sales channels. We export to more than 30 countries. Certis Biologicals traces its roots to some of the early leaders in the development of biological and botanical pesticides, beginning with the formation of Thermo Trilogy in 1996 and the acquisition of Neem Technologies from W.R. Grace. Since then, the company has grown by identifying and acquiring products that complement its product line. These include baculovirus products acquired from Biosys in 1997 and Bt bioinsecticide products acquired from Novartis in 1997 and Ecogen in 2002. In 2001, Mitsui & Co., a leading Japanese trading company, acquired Thermo Trilogy and renamed it Certis U.S.A. L.L.C. Within Mitsui's AgriScience Division, Certis Biologicals is positioned as the global competence center for biological control technologies. Today the company’s product line represents some of finest bioproducts and active ingredients in the industry.